ATE108993T1 - Lichtschutz. - Google Patents

Lichtschutz.

Info

Publication number
ATE108993T1
ATE108993T1 AT91909455T AT91909455T ATE108993T1 AT E108993 T1 ATE108993 T1 AT E108993T1 AT 91909455 T AT91909455 T AT 91909455T AT 91909455 T AT91909455 T AT 91909455T AT E108993 T1 ATE108993 T1 AT E108993T1
Authority
AT
Austria
Prior art keywords
light protection
light
nicotinamide
systemic
skin
Prior art date
Application number
AT91909455T
Other languages
German (de)
English (en)
Inventor
Gerhard Prof Dr Weber
Original Assignee
Weber Gerhard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Weber Gerhard filed Critical Weber Gerhard
Application granted granted Critical
Publication of ATE108993T1 publication Critical patent/ATE108993T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Liquid Crystal (AREA)
  • Prostheses (AREA)
  • Glass Compositions (AREA)
AT91909455T 1990-06-13 1991-05-24 Lichtschutz. ATE108993T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4018964A DE4018964C1 (enExample) 1990-06-13 1990-06-13

Publications (1)

Publication Number Publication Date
ATE108993T1 true ATE108993T1 (de) 1994-08-15

Family

ID=6408360

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91909455T ATE108993T1 (de) 1990-06-13 1991-05-24 Lichtschutz.

Country Status (8)

Country Link
EP (1) EP0486632B1 (enExample)
JP (1) JPH0635387B2 (enExample)
AT (1) ATE108993T1 (enExample)
AU (1) AU645092B2 (enExample)
CA (1) CA2059641A1 (enExample)
DE (2) DE4018964C1 (enExample)
ES (1) ES2061248T3 (enExample)
WO (1) WO1991019478A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4341001A1 (de) * 1993-12-02 1995-06-08 Beiersdorf Ag Topische Zubereitungen mit einem Gehalt an L-Arginin
US5759524A (en) * 1996-02-09 1998-06-02 The Procter & Gamble Company Photoprotective compositions
FR2775434B1 (fr) * 1998-02-27 2000-05-19 Oreal Compositions cosmetiques pour la photoprotection de la peau et/ou des cheveux a base d'un melange synergique de filtres et utilisations
DE10021468A1 (de) * 2000-05-04 2001-11-08 Basf Ag Verwendung von PARP-Inhibitoren in kosmetischen Zubereitungen
DE10062401A1 (de) * 2000-12-14 2002-06-20 Beiersdorf Ag Verwendung von Folsäure und/oder deren Derivaten zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Prophylaxe von Schäden an der hauteigenen DNA und/oder zur Reparatur bereits eingetretener Schäden an der hauteigenen DNA
CH696628A5 (de) * 2002-02-26 2007-08-31 Eprova Ag Verwendung von Folaten zur Herstellung einer Zubereitung geeignet zur Vorbeugung und Behandlung von Entzündungen und entzündungsassoziierter Krankheiten, im Speziellen zur Beeinflussung der
US20040191278A1 (en) 2003-03-31 2004-09-30 Christensen Flemming Kjaergaar Topical agent for application to the skin prior to luminous treatment
FR2894142B1 (fr) * 2005-12-05 2009-06-12 Oreal Utilisation de l'association du dipeptide tyrosine-arginine et de la niacimanide en tant qu'antagoniste de substance p
US8858968B2 (en) 2005-12-05 2014-10-14 L'oreal Use of tyrosine-arginine dipeptide and niacinamide as substance P antagonist
KR101275351B1 (ko) * 2010-06-29 2013-06-17 (주)아모레퍼시픽 노화방지용 화장료 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2096712A1 (en) * 1970-06-29 1972-02-25 Giraux Georges Steroid/b group vitamin compsns - for prevention and treatment of skin-photosensitivity disorders
DE2242553A1 (de) * 1972-08-30 1974-03-07 Koehler Valentin Kosmetisches mittel
JPS59173124A (ja) * 1983-03-19 1984-10-01 Shiseido Co Ltd 乳化組成物
LU87145A1 (fr) * 1988-02-26 1989-09-20 Oreal Methode pour ameliorer l'aspect esthetique de la peau a l'aide de melanges polyvitaminiques

Also Published As

Publication number Publication date
DE59102350D1 (de) 1994-09-01
JPH05500230A (ja) 1993-01-21
WO1991019478A1 (de) 1991-12-26
JPH0635387B2 (ja) 1994-05-11
AU645092B2 (en) 1994-01-06
EP0486632B1 (de) 1994-07-27
ES2061248T3 (es) 1994-12-01
CA2059641A1 (en) 1991-12-14
EP0486632A1 (de) 1992-05-27
DE4018964C1 (enExample) 1991-07-04
AU7865791A (en) 1992-01-07

Similar Documents

Publication Publication Date Title
FI962022L (fi) 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina
ES2104673T3 (es) Hidroximetil(metilenciclopentil)purinas y pirimidinas.
FI946058L (fi) Paikalliseen käyttöön tarkoitettu galeeninen koostumus
BR9306371A (pt) Composições refrescantes
AR015379A1 (es) Ascorbil-fosforil-colesterol
DK0425650T3 (da) Antiinflammatoriske 4-aminophenolderivater
ITRM910133A0 (it) Dispositivo manuale per la applicazione di segmenti di nastri di mascheratura su superfici da proteggere.
DE59102350D1 (de) Lichtschutz.
FI962021L (fi) 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina
IT8024827A0 (it) Impiego dell'alfa-chetoglutarato di piridossina nella profilassi della iperlattacidemia.
ATE221780T1 (de) Fenbendazolformulierungen
ES2178765T3 (es) Nuevos derivados de 1,7,7-trimetil-biciclo (2.2.1) heptano.
NO911459D0 (no) Anvendelse av metallion-komplekser som belegginhibitorer.
PT910367E (pt) Uso de acetato de vitamina e
IT1232710B (it) Impiego dell acido 2 idrossi 4 metossibenzofenon 5 solfonico o di suoi sali per la protezione dei capelli contro le aggressioni atmosferiche in particolare contro la luce, e procedimento per la protezione dei capelli utilizzante tale composto
BG100248A (bg) Инхибитори на скваленсинтетаза
IT1252603B (it) 2,4-diamino-6 piperidino pirimidina-3 ossido topico sul glande nel trattamento delle impotenze erettili
ES2075272T5 (es) Composiciones dermatologicas conteniendo acido cis-urocanico.
NO922805L (no) Topisk sopphemmende middel med betennelsesmotvirkende aktivitet
DE3869156D1 (de) Fungizide 2-anilinthiazoline.
BE844755A (fr) Nouvelles diamino-2,4 (p-aminobenzyl)-5 pyrimidines, utiles notamment comme agents antibacteriens
ATE118007T1 (de) Penemderivate.
ITBZ920042A0 (it) Dispositivo per l'applicazione di tratti di nastro o di bigliettini su pezzi da lavorare
FI962020L (fi) Pyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina
FI885576L (fi) Foerfarande foer framstaellning av preparat foer minskning av flebektasi.